X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CLINICAL SCIENCE

期刊標題檢索 CLIN SCI 最新評論: How did it go later on? (2024-10-13)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CLINICAL SCIENCE]您好,您是該頁面的第 88281 位訪客。

期刊簡介
期刊名稱CLINICAL SCIENCE CLINICAL SCIENCE
LetPub Score
7.8
50 ratings
Rate

Reputation
8.8

Influence
6.7

Speed
9.1

期刊簡稱CLIN SCI
ISSN0143-5221
E-ISSN1470-8736
h-index126
CiteScore
CiteScoreSJRSNIPCiteScore Rank
11.401.5651.062
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: General Medicine
Q132 / 636

自引率 (2023-2024)1.50%自引率趨勢
掲載範囲
Translating molecular bioscience and experimental research into medical insights, Clinical Science offers multi-disciplinary coverage and clinical perspectives to advance human health.

Its international Editorial Board is charged with selecting peer-reviewed original papers of the highest scientific merit covering the broad spectrum of biomedical specialities including, although not exclusively:


Cardiovascular system
Cerebrovascular system
Gastrointestinal tract and liver
Genomic medicine
Infection and immunity
Inflammation
Oncology
Metabolism
Endocrinology and nutrition
Nephrology
Circulation
Respiratory system
Vascular biology
Molecular pathology.
官方網站http://www.clinsci.org/
在線稿件提交https://clinsci.msubmit.net/cgi-bin/main.plex
開放訪問No
出版商Portland Press Ltd.
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年1979
每年文章數103每年文章數趨勢
黃金OA百分比77.32%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ124/189
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0143-5221%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Ordinary
參考鏈接
相關期刊 【CLINICAL SCIENCE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    JOURNAL OF CLINICAL INVESTIGATIONH-index: 447

    CiteScore: 24.50
    EMBO Molecular MedicineH-index: 90

    CiteScore: 17.70
    JOURNAL OF BIOMEDICAL SCIENCEH-index: 71

    CiteScore: 18.50
    Journal of Translational MedicineH-index: 87

    CiteScore: 10.00
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINEH-index: 80

    CiteScore: 12.30
    JOURNAL OF MOLECULAR MEDICINE-JMMH-index: 127

    CiteScore: 9.30
    ARCHIVES OF MEDICAL RESEARCHH-index: 72

    CiteScore: 12.50
    Orphanet Journal of Rare DiseasesH-index: 87

    CiteScore: 6.30
    XENOTRANSPLANTATIONH-index: 56

    CiteScore: 6.80
    CLINICAL AND EXPERIMENTAL MEDICINEH-index: 39

    CiteScore: 4.80
    學科內最受檢索的期刊 頁面查看次數
    Journal of Translational Medicine258025
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE175251
    JOURNAL OF CLINICAL INVESTIGATION168423
    JOURNAL OF BIOMEDICAL SCIENCE131674
    MEDICAL HYPOTHESES102909
    MEDICAL SCIENCE MONITOR84778
    Advances in Experimental Medicine and Biology81192
    EMBO Molecular Medicine79558
    EXPERIMENTAL BIOLOGY AND MEDICINE76105
    JOURNAL OF MOLECULAR MEDICINE-JMM75400
  •  

    CLINICAL SCIENCE CLINICAL SCIENCE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)
  [CLINICAL SCIENCE] 的評論撰寫評論
作者: 如来伟懋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-13 08:34:14 評論於
How did it go later on?
(0) 讚! | 如来伟懋

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-04 15:17:11 評論於
Generally, between 4-10 weeks, the quality of the manuscript should still be relatively high.
(0) 讚! | Adelaide Lawson

作者: 百花婷婷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-03 23:39:27 評論於
How about the review period?
(0) 讚! | 百花婷婷

作者: 百花婷婷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-03 14:25:54 評論於
Just finished the game.
(0) 讚! | 百花婷婷

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-23 16:43:26 評論於
This situation is indeed a bit strange. The first status indicates rejection, followed by peer review. It may be a problem with the system status. You can contact the editorial department.
(0) 讚! | Adelaide Lawson

作者: 洗髓梓睿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-05 14:48:50 評論於
What does "manuscript rejected" followed by "in review" mean? Does it mean rejection and should I withdraw the submission and send it to another journal?
(0) 讚! | 洗髓梓睿

作者: 水竹小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-18 18:33:37 評論於
I'm not sure
(0) 讚! | 水竹小公主

作者: 水竹小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-18 11:38:58 評論於
No need to change the title, follow the instructions to complete the experiment and resubmit
(0) 讚! | 水竹小公主

作者: 傲桃mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-14 14:30:16 評論於
Research Focus: Tumor Experience Sharing: Can kick about every four months
(0) 讚! | 傲桃mio

作者: 盛夏了夏


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2023-11-21 12:13:44 評論於
I think it's not bad. I was rejected instantly when I submitted it for the first time, but fortunately I was given the reason for rejection. When I looked at the reason for rejection, it was not valid, the editor just didn't read my article carefully. So I made some changes to the article, submitted it again, and explained the editor's doubts. The editor helped me send it for external review. Two months later, I received suggestions for major revisions, but in fact there were only a few simple issues, and suggested that I do some additional experiments. I did not make the additional experiments, but explained the reasons and opinions why I did not do the experiments. I submitted it again and it was accepted directly. Ah, I'm really happy
(3) 讚! | 盛夏了夏

作者: 排云一然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-17 17:17:36 評論於
Hello, may I ask if you accept articles with only clinical specimens?
(0) 讚! | 排云一然

作者: 墟散若曦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-03 13:02:10 評論於
How about the following article?
(0) 讚! | 墟散若曦

作者: Muriel Sapir


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-07 23:38:28 評論於
How to resubmit after being rejected? Do I need to change the manuscript title?
(0) 讚! | Muriel Sapir

作者: Muriel Sapir


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-07 10:26:01 評論於
Can I resubmit after being rejected? Do I need to change the title?
(0) 讚! | Muriel Sapir

作者: 书生永寿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-08 15:06:54 評論於
"In review" is a status that comes before a decision is made
(0) 讚! | 书生永寿

作者: 书生永寿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-13 18:06:33 評論於
Research focus: Clinical combined with basic research
Share experience: Under peer review for two months, decision pending, then changed to in review, what does this mean?
(0) 讚! | 书生永寿

作者: 小野寺展鹏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-26 11:14:01 評論於
Submission acceptance rate: 50.0
Research focus: Lung injury; Sepsis
Submission experience: Submitted on July 1st, was notified after 3 days that the image resolution was not high enough and requested to submit the original Western blot image. Resubmitted on July 5th with the correct image. A few days later, it was rejected with no reason given, just stating it was not suitable
(0) 讚! | 小野寺展鹏

作者: 瑜蓓小姐姐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-11 16:55:04 評論於
I am in the same situation now, how about you guys?
(0) 讚! | 瑜蓓小姐姐

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:24:59 評論於
Currently ORCID is optional, not mandatory. However, it is important to note that most publishers (including Elsevier, Wiley, Nature, Thomsen Reuters) now require all researchers associated with their publications to use an ORCID iD.
If an article is published without providing an ORCID ID, how to add it?
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:13:09 評論於
Article Manuscript
(0) 讚! | 维尔娜菲茨杰拉德

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 15:10:36 評論於
Is it necessary to provide the ORCID iD of each author when submitting a manuscript?
(0) 讚! | 龙鳞孝礼

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 14:30:59 評論於
What is MS?
(0) 讚! | 深渊兴业

作者: 水竹小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-27 09:01:23 評論於
Review speed: 2.0 | Submission hit rate: 25.0 Experience sharing: After being rejected and resubmitted, the first revision took a total of 160 days, and it was just accepted
(0) 讚! | 水竹小公主

作者: 博学小可爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-22 10:12:50 評論於
Hello, I am currently in the same situation as well. How did things go for you afterwards?
(0) 讚! | 博学小可爱

作者: 苍风从易


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-30 22:36:35 評論於
Okay, thank you
(0) 讚! | 苍风从易

首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)

開始撰寫 [CLINICAL SCIENCE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*